Literature DB >> 20961373

Increasing time delay from presentation until surgical referral for hepatobiliary malignancies.

Kristopher P Croome1, Robyn Chudzinski, Douglas W Hanto.   

Abstract

BACKGROUND: Studies have shown that delayed treatment of several non-hepatobiliary (HB) malignancies is associated with adverse effects on disease progression and survival. Delayed treatment of HB malignancies has not been thoroughly investigated.
METHODS: We performed a retrospective institutional review of patients referred to the Hepatobiliary Surgery Service at Beth Israel Deaconess Medical Center (BIDMC) for hepatobiliary malignancies from 2002 to 2008. Primary outcomes included the time delays (TD) in patient workup. Secondary outcomes were reasons for delay as well as disparities in TD based on demographic factors.
RESULTS: Multivariate-adjusted linear regression showed a significant trend of increasing time from presentation until referral to a HB surgeon over the 7-year period (P= 0.001). There were no differences in TD by gender, age or education level. Multivariate-adjusted linear regression showed a significant trend of increasing number of imaging tests performed prior to referral [computerized tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET) and ultrasound and endoscopic ultrasound (US/EUS)] (P < 0.001). Multivariate-adjusted linear regression in resectable patients showed a significant difference in overall length of survival in those with a TD1 > 30 days compared with those with a TD1 (TD from presentation until referral) <30 days (P = 0.042).
CONCLUSIONS: Delays were associated with an increase in imaging studies and delays adversely affect survival in resected patients. Referring physicians are encouraged to expedite the evaluation and early referral of all patients to an HB surgeon for evaluation and treatment.
© 2010 International Hepato-Pancreato-Biliary Association.

Entities:  

Mesh:

Year:  2010        PMID: 20961373      PMCID: PMC2999792          DOI: 10.1111/j.1477-2574.2010.00217.x

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  11 in total

1.  Racial disparity in primary hepatocellular carcinoma: tumor stage at presentation, surgical treatment and survival.

Authors:  Dana Sloane; Hegang Chen; Charles Howell
Journal:  J Natl Med Assoc       Date:  2006-12       Impact factor: 1.798

2.  The impact of delayed diagnosis of lung cancer on the stage at the time of operation.

Authors:  E D Christensen; T Harvald; M Jendresen; S Aggestrup; G Petterson
Journal:  Eur J Cardiothorac Surg       Date:  1997-12       Impact factor: 4.191

3.  Effect on survival of delays in referral of patients with breast-cancer symptoms: a retrospective analysis.

Authors:  R Sainsbury; C Johnston; B Haward
Journal:  Lancet       Date:  1999-04-03       Impact factor: 79.321

4.  Delay in the diagnosis and outcome of colorectal cancer: a prospective study.

Authors:  L Roncoroni; N Pietra; V Violi; L Sarli; O Choua; A Peracchia
Journal:  Eur J Surg Oncol       Date:  1999-04       Impact factor: 4.424

5.  Delay in the diagnosis and treatment of primary bone sarcoma of the pelvis.

Authors:  L D Wurtz; T D Peabody; M A Simon
Journal:  J Bone Joint Surg Am       Date:  1999-03       Impact factor: 5.284

6.  Delay in diagnosis of lung cancer in general practice.

Authors:  Marianne Bjerager; Torben Palshof; Ronald Dahl; Peter Vedsted; Frede Olesen
Journal:  Br J Gen Pract       Date:  2006-11       Impact factor: 5.386

7.  Delays in diagnosis and melanoma prognosis (I): the role of patients.

Authors:  M A Richard; J J Grob; M F Avril; M Delaunay; J Gouvernet; P Wolkenstein; P Souteyrand; B Dreno; J J Bonerandi; S Dalac; L Machet; J C Guillaume; J Chevrant-Breton; C Vilmer; F Aubin; B Guillot; M Beylot-Barry; C Lok; N Raison-Peyron; P Chemaly
Journal:  Int J Cancer       Date:  2000-05-20       Impact factor: 7.396

8.  Survival impact of delayed treatment in patients with hepatocellular carcinoma undergoing locoregional therapy: is there a lead-time bias?

Authors:  Teh-Ia Huo; Yi-Hsiang Huang; Jen-Huei Chiang; Jaw-Ching Wu; Pui-Ching Lee; Chin-Wen Chi; Shou-Dong Lee
Journal:  Scand J Gastroenterol       Date:  2007-04       Impact factor: 2.423

9.  Delay in diagnosis and treatment of symptomatic colorectal cancer.

Authors:  H W Holliday; J D Hardcastle
Journal:  Lancet       Date:  1979-02-10       Impact factor: 79.321

View more
  3 in total

1.  Surgical Delay Is Associated with Improved Survival in Hepatocellular Carcinoma: Results of the National Cancer Database.

Authors:  Kerui Xu; Shinobu Watanabe-Galloway; Fedja A Rochling; Paraskevi A Farazi; K M Monirul Islam; Hongmei Wang; Jiangtao Luo
Journal:  J Gastrointest Surg       Date:  2018-09-04       Impact factor: 3.452

2.  Time-to-Surgery and Survival Outcomes in Resectable Colorectal Liver Metastases: A Multi-Institutional Evaluation.

Authors:  Julie N Leal; Alexsander K Bressan; Neeta Vachharajani; Mithat Gonen; T Peter Kingham; Michael I D'Angelica; Peter J Allen; Ronald P DeMatteo; Majella B M Doyle; Oliver F Bathe; Paul D Greig; Alice Wei; William C Chapman; Elijah Dixon; William R Jarnagin
Journal:  J Am Coll Surg       Date:  2016-01-30       Impact factor: 6.113

3.  Therapeutic Underuse and Delay in Hepatocellular Carcinoma: Prevalence, Associated Factors, and Clinical Impact.

Authors:  Rajalakshmi Govalan; Michael Luu; Marie Lauzon; Kambiz Kosari; Joseph C Ahn; Nicole E Rich; Nicholas Nissen; Lewis R Roberts; Amit G Singal; Ju Dong Yang
Journal:  Hepatol Commun       Date:  2021-08-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.